The Funding statement had an error in the reference of one project. Instead of PTDC/EMD-TLM/4644/2021, it should be PTDC/EMD-TLM/7289/2020.
Funding
This work was supported by UID/BIM/50005/2019 and PTDC/EMD-TLM/7289/2020, a project funded by Fundação para a Ciência e a Tecnologia - Ministério da Ciência, Tecnologia e Ensino Superior (FCT-MCTES), through Fundos do Orçamento de Estado (Portugal). CSL also acknowledges FCT-MCTES fellowship PD/BD/135045/2017.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
amyotrophic lateral sclerosis, prognosis, respiratory function, survival, gamma′ fibrinogen
Citation
Pronto-Laborinho AC, Lopes CS, Conceição VA, Gromicho M, Santos NC, de Carvalho M and Carvalho FA (2021) Corrigendum: γ′ Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis. Front. Cardiovasc. Med. 8:800151. doi: 10.3389/fcvm.2021.800151
Received
22 October 2021
Accepted
25 October 2021
Published
15 November 2021
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
8 - 2021
Updates
Copyright
© 2021 Pronto-Laborinho, Lopes, Conceição, Gromicho, Santos, de Carvalho and Carvalho.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Filomena A. Carvalho filomenacarvalho@medicina.ulisboa.pt
†These authors have contributed equally to this work and share first authorship
This article was submitted to Thrombosis, a section of the journal Frontiers in Cardiovascular Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.